NCT04539366 2025-11-03Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, The GD2-CAR PERSIST TrialNational Cancer Institute (NCI)Phase 1 Suspended67 enrolled
NCT04897321 2025-10-24B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)St. Jude Children's Research HospitalPhase 1 Recruiting32 enrolled
NCT04530487 2025-06-29Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young AdultsM.D. Anderson Cancer CenterPhase 2 Terminated1 enrolled 7 charts
NCT00084695 2014-01-10Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant DiseasesNational Cancer Institute (NCI)Phase 2 Unknown25 enrolled